AstraZeneca, Breast Cancer
AstraZeneca’s Datroway approved in U.S. for HER2-negative breast cancer patients
DXd, has been approved in the US for the treatment of adult patients with unresectable or metastatic hormone receptor HR-positive, HER2-negative breast cancer who have received prior endocrine-based therapy and chemotherapy for unresectable or metastatic disease.
A breast cancer survivor received an unexpected gift this week from Tina's Angels, a national organization dedicated to creating lasting memories for families a ...
Danielle Fishel is sharing an update about her health, saying she has completed “active cancer treatment” following her ...
The increase in breast cancer rates among younger patients is occurring as the incidence of other early-onset cancers — ...
The FDA has approved AstraZeneca and Daiichi Sankyo’s Datroway (datopotamab deruxtecan-dlnk) to treat unresectable or ...
"Boy Meets World" star Danielle Fishel said she is finished with radiation treatment for cancer and opened up about the side ...
Breast cancer is the second leading cause of cancer death in women. Early detection results in 99% five-year survival rates.
Morgan Pressel's 18th annual Morgan & Friends event raised a record $1,022,000 to support the fight against breast cancer.
If you have breast cancer, you will have changes in your breast. These may be lumps or changes in the size or color of your breast, or changes in the appearance of your nipples. Breast cancer ...
The US Food and Drug Administration (FDA) has approved datopotamab deruxtecan for the treatment of certain patients with ...
From awareness to advocacy, Karen Bonds has come full circle—turning her battle into a mission to ensure that no one fights breast cancer alone.
Questions about sex and intimacy often go unanswered for people with cancer. It's a glaring problem, especially for the ...
As cancer treatment costs have increased, identifying and treating early-stage cancer sooner reduces expenses and improves ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback